{"id":30347,"date":"2014-09-04T10:53:51","date_gmt":"2014-09-04T14:53:51","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30347"},"modified":"2014-09-04T10:53:51","modified_gmt":"2014-09-04T14:53:51","slug":"will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347","title":{"rendered":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)?"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/04\/2014 (wallstreetpr) \u2013\u00a0Even though the much-talked about merger deal between <strong>Pfizer Inc. (NYSE:PFE) <\/strong>and <strong>AstraZeneca plc (ADR) (NYSE:AZN)<\/strong> died down, but according to the U.K. acquisition rules, the former still has chances of bringing the deal on the table.<\/p>\n<p style=\"text-align: justify;\">Even though the deal cancellation was a relief for British Pharma, but as per the <a href=\"http:\/\/online.wsj.com\/articles\/astrazeneca-targeted-washington-to-fend-off-pfizer-1409778452?mod=yahoo_hs\"><strong>Office for National Statistics<\/strong><\/a> in U.K., the number of such mergers or acquisitions in U.K. has taken a new low in 2Q2014, which means that a lot more companies perhaps retracted.<\/p>\n<p style=\"text-align: justify;\"><strong>Pfizer Still has a Chance<\/strong><\/p>\n<p style=\"text-align: justify;\">Pfizer Inc. (NYSE:PFE) pulled away its hand from the $116 billion proposed deal with Astra in May 2014, but the rules say that there can still be chances for the company to infuse life into this deal. What holds, however, is the U.S. lawmakers&#8217; intervention in context with tax inversion. According to Bloomberg, Pfizer might face some hard obstacles in future, which means that it will be left with no other option except some acquisition and the brightest and most-speculated one at this time is that with Astra.<\/p>\n<p style=\"text-align: justify;\">\u00a0The attempt of company to acquire Astra was among those mergers which attracted Washington into this tax inversion debate, where economic risks within U.S. came into limelight.<\/p>\n<p style=\"text-align: justify;\"><strong>U.K. M &amp; A at Record Low<\/strong><\/p>\n<p style=\"text-align: justify;\">Official figures reveal that the M&amp;A\u2019s dropped down to 73 in a time span of three months, record low since 1987. Out of this figure, 37 were within the geographical boundaries of the country, while only 17 of the overseas companies were acquired by U.K. ventures. Apart from this, 19 involved foreign acquisitions of U.K. ventures.<\/p>\n<p style=\"text-align: justify;\"><strong>Transactions Value Dropping<\/strong><\/p>\n<p style=\"text-align: justify;\">At the same time, the value of transactions on an average is also seeing a downward trend. From \u00a31.6bn in Q1 2014 to \u00a31.2bn in Q2 2014, the country-wide transactions are also witnessing a drop down.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/04\/2014 (wallstreetpr) \u2013\u00a0Even though the much-talked about merger deal between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN) died down, but according to [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":27742,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4503,4504,993,2745],"stock_ticker":[],"class_list":["post-30347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astrazeneca-plc-adr-nyseazn","tag-nyseazn","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/04\/2014 (wallstreetpr) \u2013\u00a0Even though the much-talked about merger deal between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN) died down, but according to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-04T14:53:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alan Masterson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alan Masterson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\"},\"author\":{\"name\":\"Alan Masterson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\"},\"headline\":\"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)?\",\"datePublished\":\"2014-09-04T14:53:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"keywords\":[\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"NYSE:AZN\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\",\"name\":\"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"datePublished\":\"2014-09-04T14:53:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\",\"name\":\"Alan Masterson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"caption\":\"Alan Masterson\"},\"description\":\"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347","og_locale":"en_US","og_type":"article","og_title":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR","og_description":"Boston, MA 09\/04\/2014 (wallstreetpr) \u2013\u00a0Even though the much-talked about merger deal between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN) died down, but according to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-04T14:53:51+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Alan Masterson","twitter_misc":{"Written by":"Alan Masterson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347"},"author":{"name":"Alan Masterson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90"},"headline":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)?","datePublished":"2014-09-04T14:53:51+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","keywords":["Astrazeneca Plc (ADR) (NYSE:AZN)","NYSE:AZN","NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347","url":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347","name":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","datePublished":"2014-09-04T14:53:51+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Pfizer-Inc..jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/will-pfizer-inc-nysepfe-make-an-attempt-acquire-astrazeneca-plc-adr-nyseazn-30347#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Will Pfizer Inc. (NYSE:PFE) Make An Attempt Acquire Astrazeneca Plc (ADR) (NYSE:AZN)?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90","name":"Alan Masterson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","caption":"Alan Masterson"},"description":"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30347"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30347\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/27742"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30347"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}